Healthcare -
Biotechnology - NASDAQ - US
$ 53.55
-0.557 %
$ 6.6 B
Market Cap
14.24
P/E
HALO - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities HALO - Halozyme Therapeutics, Inc.
-263 M
LAST VALUE
26.55%
2 YEAR CAGR
-116.30%
5 YEAR CAGR
-23.07%
10 YEAR CAGR